Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1998-06-23
Mullis, Jeffrey
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31425
Patent
active
057706166
ABSTRACT:
A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals that comprises a material is disclosed. The particular material used is a 1H-1,2,4-triazole derivative. These compounds can also be used to treat viral infections.
REFERENCES:
patent: 4079062 (1978-03-01), Van Reet et al.
patent: 4160838 (1979-07-01), Van Reet et al.
patent: 4490540 (1984-12-01), Heeres
patent: 5114951 (1992-05-01), King
patent: 5211736 (1993-05-01), Lai
Schwartz, "Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patents with acute promyelocytic leukemia," Biochemical Pharmacology, vol. 50, No. 7, 923-928, (1995).
Copending application of J. B. Camden, Ser. No. 08/473,818 filed Jun. 7, 1995.
Copending application of J. B. Camden, Ser. No. 08/674,180 filed Jul. 16, 1996.
Copending application of J. B. Camden, Ser. No. 08/674,182 filed Jul. 16, 1996.
Dabek Rose Ann
Mullis Jeffrey
Rasser J. C.
The Procter & Gamble & Company
LandOfFree
Pharmaceutical composition for inhibiting the growth of cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for inhibiting the growth of cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for inhibiting the growth of cancers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1395101